Back to PollNow

Back to companies

Evolus, Inc.

EOLSUSNASDAQPharmaceuticals & Healthcare

Evolus, Inc.

Revenue

$297.2mn

YoY +11.6%

Operating income

-$32.7mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API